4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-22-021185
Chief Commercial Officer acquired 3,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Deardorf Caren Chief Commercial Officer | 2022-05-31 | Grant or award | +3,000 | $0.99 | $2,970 | 16,762 | D |
Loading xslF345X03/doc4.xml…